Timber Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Timber Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 72% to $83,177. Profit margin reached -23299%. Total operating expenses were $19,235,396.

Profit Margin

Timber Pharmaceuticals, Inc. (AMEX:TMBR): Profit margin
2013 0 -52.30K
2014 0 0
2016 64K -15.59M -24371.87%
2018 73K -8.97M -12298.63%
2019 57K -17.25M -30277.19%
2020 453.81K -15.11M -3331.27%
2021 295.73K -10.63M -3597.49%
2022 83.17K -19.37M -23299.05%

TMBR Income Statement (2013 – 2022)

2022 2021 2020 2018 2017 2015 2014 2013
Revenue
Revenue
83.17K295.73K453.81K57K73K64K00
Cost of revenue
13.30M6.14M1.50M83K250K237K00
Gross profit
-13.21M-5.85M-1.04M-26K-177K-173K00
Operating exp.
Research and development
13.30M6.14M15.10M9.07M9.14M5.70M00
Selling and marketing
0002.15M2.41M5.10M00
Total operating expenses
19.23M10.94M18.71M16.48M16.69M14.98M052.30K
Operating income
-19.23M-10.65M-20.21M-17.22M-23.93M-15.59M0-52.30K
Other income (expenses), net
-136.45K-19.17K5.13M-28K238K-436K01
Income before tax
-19.37M-10.66M-15.07M-17.25M-16.63M-15.59M0-52.30K
Income tax expense
7.6K-30.24K37.84K2K-7.66M4K00
Net income
-19.37M-10.63M-15.11M-17.25M-8.97M-15.59M0-52.30K
Earnings per share
Basic EPS
-9.19-13.15-48.15-1.34K-1.56K-13.03K0-0.00
Diluted EPS
-9.19-13.15-48.15-1.34K-1.56K-13.03K0-0.00
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source